Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
  1. Home
  2. Publications
  3. Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy

Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy

Authors:
  • DKDong-In Koh
    Dong-In Koh
  • MLMinki Lee
    Minki Lee
  • YPYoon Sun Park
    Yoon Sun Park
  • JSJae-Sik Shin
    Jae-Sik Shin
  • JKJoseph Kim
    Joseph Kim
  • YRYea Seong Ryu
    Yea Seong Ryu
  • JLJun Hyung Lee
    Jun Hyung Lee
  • SBSeunggeon Bae
    Seunggeon Bae
  • MLMi So Lee
    Mi So Lee
  • JHJun Ki Hong
    Jun Ki Hong
  • HJHong-Rae Jeong
    Hong-Rae Jeong
  • MCMingee Choi
    Mingee Choi

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32702767
Abstract
IGSF1 targeting antibody is developed and characterized by various methods
Keywords
  • IMMUNE SUPPRESSOR
  • CANCER IMMUNOTHERAPY
  • SUPPLEMENTARY FIGURE
  • POTENTIAL TARGET
  • TARGETING ANTIBODY
  • FIGURE
  • SUPPRESSOR
  • IMMUNOTHERAPY
  • IMMUNE
  • POTENTIAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.